Physician profile
Nicholas E Anthony
NPI 1265607907
$6,328.83
in general payments reported to CMS, 2019-2025
9 companies · $5,567 in 2025
The $5,567 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.82 · 2021: $30.79 · 2022: $508 · 2023: $25.57 · 2024: $160 · 2025: $5,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,520 · Food and Beverage: $667 · Consulting Fee: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,520.00 |
| Food and Beverage | $667.36 |
| Consulting Fee | $565.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $4,520.00 | 2025 | |
| Cook Incorporated | $565.00 | 2025 | Hemospray |
| Cook Medical LLC | $443.85 | 2019-2025 | Hemospray |
| Medtronic, INC. | $383.56 | 2022 | |
| Revance Therapeutics, INC. | $138.02 | 2024 | Daxxify |
| Abbvie INC. | $124.30 | 2022 | |
| Janssen Biotech, INC. | $97.74 | 2025 | Tremfya |
| Novo Nordisk INC | $30.79 | 2021 | |
| Olympus America INC. | $25.57 | 2023 | Endoclot Phs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.